SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-016673
Filing Date
2022-08-11
Accepted
2022-08-11 08:45:42
Documents
49
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q labp-20220630.htm   iXBRL 10-Q 1830127
2 EX-10.1 labp-ex10_1.htm EX-10.1 79292
3 EX-10.2 labp-ex10_2.htm EX-10.2 220042
4 EX-31.1 labp-ex31_1.htm EX-31.1 27146
5 EX-32.1 labp-ex32_1.htm EX-32.1 16373
  Complete submission text file 0000950170-22-016673.txt   6570813

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT labp-20220630_cal.xml EX-101.CAL 33362
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT labp-20220630_lab.xml EX-101.LAB 321361
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT labp-20220630_pre.xml EX-101.PRE 223653
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT labp-20220630.xsd EX-101.SCH 32071
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT labp-20220630_def.xml EX-101.DEF 119487
43 EXTRACTED XBRL INSTANCE DOCUMENT labp-20220630_htm.xml XML 1143326
Mailing Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060
Business Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060 540-818-2844
Landos Biopharma, Inc. (Filer) CIK: 0001785345 (see all company filings)

IRS No.: 815085535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39971 | Film No.: 221153878
SIC: 2834 Pharmaceutical Preparations